Works by Groot, John

Results: 125

Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs.

Published in:

2009

By:

Agterberg, Martijn;
Versnel, Huib;
Dijk, Lotte;
Groot, John;
Klis, Sjaak;
Agterberg, Martijn J H;
van Dijk, Lotte M;
de Groot, John C M J;
Klis, Sjaak F L

Publication type:

journal article

Long-term survival among 5-year survivors of adolescent and young adult cancer.

Published in:

2020

By:

Berkman, Amy M.;
Livingston, J. A.;
Merriman, Kelly;
Hildebrandt, Michelle;
Wang, Jian;
Dibaj, Seyedeh;
McQuade, Jennifer;
You, Nancy;
Ying, Anita;
Barcenas, Carlos;
Bodurka, Diane;
DePombo, April;
Lee, Hun Ju;
Groot, John;
Roth, Michael;
de Groot, John

Publication type:

journal article

Treatment strategies for glioblastoma in older patients: age is just a number.

Published in:

Journal of Neuro-Oncology, 2019, v. 145, n. 2, p. 357, doi. 10.1007/s11060-019-03304-x

By:

Youssef, Michael;
Ludmir, Ethan B.;
Mandel, Jacob J.;
Patel, Akash J.;
Jalali, Ali;
Treiber, Jeffrey;
Wu, Jimin;
McAleer, Mary Frances;
de Groot, John F.

Publication type:

Article

Effect of health disparities on overall survival of patients with glioblastoma.

Published in:

Journal of Neuro-Oncology, 2019, v. 142, n. 2, p. 365, doi. 10.1007/s11060-019-03108-z

By:

Mandel, Jacob J.;
Youssef, Michael;
Nam, Jooyeon;
Patel, Akash J.;
Jalali, Ali;
Ludmir, Ethan B.;
Liu, Diane;
Wu, Jimin;
Armstrong, Georgina;
Huse, Jason;
Bondy, Melissa;
de Groot, John F.

Publication type:

Article

The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study.

Published in:

Journal of Neuro-Oncology, 2018, v. 140, n. 3, p. 591, doi. 10.1007/s11060-018-2985-3

By:

Ding, Xiaojie;
Wang, Zheng;
Chen, Di;
Wang, Yinyan;
Zhao, Zheng;
Sun, Chongran;
Chen, Dikang;
Tang, Chao;
Xiong, Ji;
Chen, Lingchao;
Yao, Zhenwei;
Liu, Ying;
Wang, Xiaoqin;
Cahill, Daniel P.;
de Groot, John F.;
Jiang, Tao;
Yao, Yu;
Zhou, Liangfu

Publication type:

Article

Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.

Published in:

Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 125, doi. 10.1007/s11060-018-2850-4

By:

Kotrotsou, Aikaterini;
Elakkad, Ahmed;
Sun, Jia;
Thomas, Ginu A.;
Yang, Dongni;
Abrol, Srishti;
Wei, Wei;
Weinberg, Jeffrey S.;
Bakhtiari, Ali S.;
Kircher, Moritz F.;
Luedi, Markus M.;
de Groot, John F.;
Sawaya, Raymond;
Kumar, Ashok J.;
Zinn, Pascal O.;
Colen, Rivka R.

Publication type:

Article

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.

Published in:

Journal of Neuro-Oncology, 2017, v. 132, n. 1, p. 181, doi. 10.1007/s11060-016-2357-9

By:

Nayak, Lakshmi;
Groot, John;
Wefel, Jeffrey;
Cloughesy, Timothy;
Lieberman, Frank;
Chang, Susan;
Omuro, Antonio;
Drappatz, Jan;
Batchelor, Tracy;
DeAngelis, Lisa;
Gilbert, Mark;
Aldape, Kenneth;
Yung, Alfred;
Fisher, Joy;
Ye, Xiaobu;
Chen, Alice;
Grossman, Stuart;
Prados, Michael;
Wen, Patrick

Publication type:

Article

Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 130, n. 3, p. 495, doi. 10.1007/s11060-016-2243-5

By:

O'Neill, Allison;
Qin, Lei;
Wen, Patrick;
Groot, John;
Abbeele, Annick;
Yap, Jeffrey

Publication type:

Article

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 487, doi. 10.1007/s11060-016-2195-9

By:

Weathers, Shiao-Pei;
Han, Xiaosi;
Liu, Diane;
Conrad, Charles;
Gilbert, Mark;
Loghin, Monica;
O'Brien, Barbara;
Penas-Prado, Marta;
Puduvalli, Vinay;
Tremont-Lukats, Ivo;
Colen, Rivka;
Yung, W.;
de Groot, John

Publication type:

Article

Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 147, doi. 10.1007/s11060-016-2157-2

By:

Mandel, Jacob;
Cachia, David;
Liu, Diane;
Wilson, Charmaine;
Aldape, Ken;
Fuller, Greg;
Groot, John

Publication type:

Article

A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.

Published in:

Journal of Neuro-Oncology, 2016, v. 126, n. 2, p. 309, doi. 10.1007/s11060-015-1966-z

By:

Robins, H.;
Zhang, Peixin;
Gilbert, Mark;
Chakravarti, Arnab;
Groot, John;
Grimm, Sean;
Wang, Fen;
Lieberman, Frank;
Krauze, Andra;
Trotti, Andy;
Mohile, Nimish;
Kee, Andrew;
Colman, Howard;
Cavaliere, Robert;
Kesari, Santosh;
Chmura, Steven;
Mehta, Minesh

Publication type:

Article

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.

Published in:

Journal of Neuro-Oncology, 2015, v. 125, n. 2, p. 401, doi. 10.1007/s11060-015-1930-y

By:

Cachia, David;
Kamiya-Matsuoka, Carlos;
Mandel, Jacob;
Olar, Adriana;
Cykowski, Matthew;
Armstrong, Terri;
Fuller, Gregory;
Gilbert, Mark;
Groot, John

Publication type:

Article

Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.

Published in:

Journal of Neuro-Oncology, 2014, v. 120, n. 3, p. 597, doi. 10.1007/s11060-014-1592-1

By:

Mandel, Jacob;
Yust-Katz, Shlomit;
Cachia, David;
Wu, Jimin;
Liu, Diane;
de Groot, John;
Yung, Alfred;
Gilbert, Mark

Publication type:

Article

Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.

Published in:

2013

By:

Grossmann, Kenneth;
Colman, Howard;
Akerley, Wallace;
Glantz, Michael;
Matsuoko, Yuko;
Beelen, Andrew;
Yu, Margaret;
Groot, John;
Aiken, Robert;
Olson, Jeffrey;
Evans, Brent;
Jensen, Randy

Publication type:

Correction Notice

Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.

Published in:

Journal of Neuro-Oncology, 2012, v. 110, n. 2, p. 257, doi. 10.1007/s11060-012-0964-7

By:

Grossmann, Kenneth;
Colman, Howard;
Akerley, Wallace;
Glantz, Michael;
Matsuoko, Yuko;
Beelen, Andrew;
Yu, Margaret;
Groot, John;
Aiken, Robert;
Olsen, Jeffery;
Evans, Brent;
Jensen, Randy

Publication type:

Article

Improving the prognosis for patients with glioblastoma: the rationale for targeting Src.

Published in:

Journal of Neuro-Oncology, 2009, v. 95, n. 2, p. 151, doi. 10.1007/s11060-009-9916-2

By:

Groot, John;
Milano, Vanessa

Publication type:

Article

Dapsone induced methemoglobinemia in a patient with glioblastoma.

Published in:

Journal of Neuro-Oncology, 2009, v. 94, n. 1, p. 149, doi. 10.1007/s11060-009-9813-8

By:

Walker, Julie;
Kadia, Tapan;
Brown, Latrondria;
Juneja, Harinder;
Groot, John

Publication type:

Article

Wernicke’s Encephalopathy: An Underrecognized and Reversible Cause of Confusional State in Cancer Patients.

Published in:

Oncology, 2009, v. 76, n. 1, p. 10, doi. 10.1159/000174951

By:

Sheng-Han Kuo;
Debnam, J. Mathew;
Fuller, Gregory N.;
de Groot, John

Publication type:

Article

Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae100

By:

Pham, Lily C;
Weller, Lauryn;
Gann, Claudia N;
Schumacher, Karl Maria;
Vlassak, Soetkin;
Swanson, Todd;
Highsmith, Kaitlin;
O'Brien, Barbara J;
Nash, Sebnem;
Aaroe, Ashley;
Groot, John F de;
Majd, Nazanin K

Publication type:

Article

Migration and fate of vestibular melanocytes during the development of the human inner ear.

Published in:

Developmental Neurobiology (19328451), 2020, v. 80, n. 11/12, p. 411, doi. 10.1002/dneu.22786

By:

Beelen, Edward S. A.;
Valk, Wouter H.;
Groot, John C. M. J.;
Hensen, Erik F.;
Locher, Heiko;
Benthem, Peter Paul G.

Publication type:

Article

Melanoma central nervous system metastases: current approaches, challenges, and opportunities.

Published in:

Pigment Cell & Melanoma Research, 2016, v. 29, n. 6, p. 627, doi. 10.1111/pcmr.12538

By:

Cohen, Justine V.;
Tawbi, Hussain;
Margolin, Kim A.;
Amravadi, Ravi;
Bosenberg, Marcus;
Brastianos, Priscilla K.;
Chiang, Veronica L.;
Groot, John;
Glitza, Isabella C.;
Herlyn, Meenhard;
Holmen, Sheri L.;
Jilaveanu, Lucia B.;
Lassman, Andrew;
Moschos, Stergios;
Postow, Michael A.;
Thomas, Reena;
Tsiouris, John A.;
Wen, Patrick;
White, Richard M.;
Turnham, Timothy

Publication type:

Article

Robust detection of oncometabolic aberrations by 1H–13C heteronuclear single quantum correlation in intact biological specimens.

Published in:

Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-1055-5

By:

Barekatain, Yasaman;
Yan, Victoria C.;
Arthur, Kenisha;
Ackroyd, Jeffrey J.;
Khadka, Sunada;
De Groot, John;
Huse, Jason T.;
Muller, Florian L.

Publication type:

Article

The Review Reviewed: Stop Publication Bias.

Published in:

Journal of Scientific Exploration, 2012, v. 26, n. 3, p. 633

By:

Alexander De Ru, J.;
De Groot, John C. M. J.;
Elshof, Jan-Willem M.

Publication type:

Article

A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives.

Published in:

Cells (2073-4409), 2024, v. 13, n. 9, p. 726, doi. 10.3390/cells13090726

By:

Montoya, Megan;
Gallus, Marco;
Phyu, Su;
Haegelin, Jeffrey;
de Groot, John;
Okada, Hideho

Publication type:

Article

Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo.

Published in:

Cells (2073-4409), 2019, v. 8, n. 12, p. 1487, doi. 10.3390/cells8121487

By:

Gammon, Seth T.;
Pisaneschi, Federica;
Bandi, Madhavi L.;
Smith, Melinda G.;
Sun, Yuting;
Rao, Yi;
Muller, Florian;
Wong, Franklin;
De Groot, John;
Ackroyd, Jeffrey;
Mawlawi, Osama;
Davies, Michael A.;
Vashisht Gopal, Y.N.;
Di Francesco, M. Emilia;
Marszalek, Joseph R.;
Dewhirst, Mark;
Piwnica-Worms, David

Publication type:

Article

Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24240-3

By:

Barekatain, Yasaman;
Ackroyd, Jeffrey J.;
Yan, Victoria C.;
Khadka, Sunada;
Wang, Lin;
Chen, Ko-Chien;
Poral, Anton H.;
Tran, Theresa;
Georgiou, Dimitra K.;
Arthur, Kenisha;
Lin, Yu-Hsi;
Satani, Nikunj;
Ballato, Elliot S.;
Behr, Eliot I.;
deCarvalho, Ana C.;
Verhaak, Roel G. W.;
de Groot, John;
Huse, Jason T.;
Asara, John M.;
Kalluri, Raghu

Publication type:

Article

Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma.

Published in:

Expert Opinion on Pharmacotherapy, 2019, v. 20, n. 13, p. 1609, doi. 10.1080/14656566.2019.1621840

By:

Majd, Nazanin;
de Groot, John

Publication type:

Article

Ouabain Does Not Induce Selective Spiral Ganglion Cell Degeneration in Guinea Pigs.

Published in:

BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/1568414

By:

Schomann, Timo;
Ramekers, Dyan;
de Groot, John C. M. J.;
van der Ploeg, Carola H.;
Hendriksen, Ferry G. J.;
Böhringer, Stefan;
Klis, Sjaak F. L.;
Frijns, Johan H. M.;
Huisman, Margriet A.

Publication type:

Article

Treatment of Glioblastoma in the Elderly.

Published in:

Drugs & Aging, 2018, v. 35, n. 8, p. 707, doi. 10.1007/s40266-018-0568-9

By:

Harrison, Rebecca A.;
de Groot, John F.

Publication type:

Article

Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept.

Published in:

Targeted Oncology, 2013, v. 8, n. 2, p. 117, doi. 10.1007/s11523-013-0254-0

By:

Shonka, Nicole;
Piao, Yuji;
Gilbert, Mark;
Yung, Alfred;
Chang, Susan;
DeAngelis, Lisa;
Lassman, Andrew;
Liu, Jun;
Cloughesy, Timothy;
Robins, H.;
Lloyd, Rita;
Chen, Alice;
Prados, Michael;
Wen, Patrick;
Heymach, John;
Groot, John

Publication type:

Article

Testing ciliary activity in patients with chronic and recurrent infections of the upper airways: Experiences in 68 cases.

Published in:

Laryngoscope, 1986, v. 96, n. 9, p. 1029, doi. 10.1288/00005537-198609000-00017

By:

Burgersdijk, Francis J. A.;
De Groot, John C. M. J.;
Graamans, Kees;
Rademakers, Louk H. P. M.

Publication type:

Article

Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 1954, doi. 10.3390/ijms21061954

By:

Khan, Sabbir;
Mittal, Sandeep;
McGee, Kain;
Alfaro-Munoz, Kristin D.;
Majd, Nazanin;
Balasubramaniyan, Veerakumar;
de Groot, John F.

Publication type:

Article

Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab.

Published in:

Journal of Neurology, 2014, v. 261, n. 8, p. 1559, doi. 10.1007/s00415-014-7292-0

By:

Theeler, Brett;
Ellezam, Benjamin;
Yust-Katz, Shlomit;
Slopis, John;
Loghin, Monica;
Groot, John

Publication type:

Article

Blood–brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.

Published in:

Journal of Neuro-Oncology, 2021, v. 151, n. 1, p. 65, doi. 10.1007/s11060-020-03425-8

By:

Beccaria, Kevin;
Sabbagh, Aria;
de Groot, John;
Canney, Michael;
Carpentier, Alexandre;
Heimberger, Amy B.

Publication type:

Article

Glutamate and the biology of gliomas.

Published in:

Glia (0894-1491), 2011, v. 59, n. 8, p. 1181, doi. 10.1002/glia.21113

By:

de Groot, John;
Sontheimer, Harald

Publication type:

Article

'Case of the Month' from The University of Texas MD Anderson Cancer Center, Houston, Texas, USA: ependymoma of the urinary bladder.

Published in:

BJU International, 2024, v. 134, n. 1, p. 45, doi. 10.1111/bju.16302

By:

Myers, Amanda A.;
Tan, Wei Shen;
de Groot, John;
Westney, Ouida Lenaine;
Kamat, Ashish M.

Publication type:

Article

Chimeric antigen receptor T-cell therapy in patients with malignant glioma—From neuroimmunology to clinical trial design considerations.

Published in:

2025

By:

Gallus, Marco;
Young, Jacob S;
Quackenbush, Sarah Cook;
Khasraw, Mustafa;
Groot, John de;
Okada, Hideho

Publication type:

Literature Review

Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.

Published in:

Neuro-Oncology, 2025, v. 27, n. 1, p. 89, doi. 10.1093/neuonc/noae214

By:

Lucas, Calixto-Hope G;
Al-Adli, Nadeem N;
Young, Jacob S;
Gupta, Rohit;
Morshed, Ramin A;
Wu, Jasper;
Ravindranathan, Ajay;
Shai, Anny;
Bush, Nancy Ann Oberheim;
Taylor, Jennie W;
Groot, John de;
Villanueva-Meyer, Javier E;
Pekmezci, Melike;
Perry, Arie;
Bollen, Andrew W;
Theodosopoulos, Philip V;
Aghi, Manish K;
Chang, Edward F;
Hervey-Jumper, Shawn L;
Raleigh, David R

Publication type:

Article

Proteasome inhibition for glioblastoma: Lessons learned and new opportunities.

Published in:

Neuro-Oncology, 2024, v. 26, n. 9, p. 1683, doi. 10.1093/neuonc/noae118

By:

Liu, S John;
Raleigh, David R;
Groot, John F de

Publication type:

Article

DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology.

Published in:

Neuro-Oncology, 2024, v. 26, n. 8, p. 1367, doi. 10.1093/neuonc/noae072

By:

Rahman, Rifaquat;
Shi, Diana D;
Reitman, Zachary J;
Hamerlik, Petra;
Groot, John F de;
Haas-Kogan, Daphne A;
D'Andrea, Alan D;
Sulman, Erik P;
Tanner, Kirk;
Agar, Nathalie Y R;
Sarkaria, Jann N;
Tinkle, Christopher L;
Bindra, Ranjit S;
Mehta, Minesh P;
Wen, Patrick Y

Publication type:

Article

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.

Published in:

Neuro-Oncology, 2023, v. 25, n. 6, p. 1017, doi. 10.1093/neuonc/noad002

By:

Ellingson, Benjamin M;
Wen, Patrick Y;
Chang, Susan M;
van den Bent, Martin;
Vogelbaum, Michael A;
Li, Gang;
Li, Shanpeng;
Kim, Jiyoon;
Youssef, Gilbert;
Wick, Wolfgang;
Lassman, Andrew B;
Gilbert, Mark R;
Groot, John F de;
Weller, Michael;
Galanis, Evanthia;
Cloughesy, Timothy F

Publication type:

Article

An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas.

Published in:

Neuro-Oncology, 2023, v. 25, n. 4, p. 808, doi. 10.1093/neuonc/noad007

By:

Gregory, Timothy A;
Williford, Garret L;
Maronge, Jacob M;
Alfaro, Kristin;
Fuller, Gregory N;
Groot, John de;
Puduvalli, Vinay K;
Ballester, Leomar Y;
Majd, Nazanin K

Publication type:

Article

Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.

Published in:

Neuro-Oncology, 2023, v. 25, n. 1, p. 137, doi. 10.1093/neuonc/noac137

By:

Rogers, C Leland;
Pugh, Stephanie L;
Vogelbaum, Michael A;
Perry, Arie;
Ashby, Lynn S;
Modi, Jignesh M;
Alleman, Anthony M;
Barani, Igor J;
Braunstein, Steve;
Bovi, Joseph A;
Groot, John F de;
Whitton, Anthony C;
Lindhorst, Scott M;
Deb, Nimisha;
Shrieve, Dennis C;
Shu, Hui-Kuo;
Bloom, Beatrice;
Machtay, Mitchell;
Mishra, Mark V;
Robinson, Clifford G

Publication type:

Article

Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 855, doi. 10.1093/neuonc/noac004

By:

Soffietti, Riccardo;
Bettegowda, Chetan;
Mellinghoff, Ingo K;
Warren, Katherine E;
Ahluwalia, Manmeet S;
Groot, John F De;
Galanis, Evanthia;
Gilbert, Mark R;
Jaeckle, Kurt A;
Rhun, Emilie Le;
Rudà, Roberta;
Seoane, Joan;
Thon, Niklas;
Umemura, Yoshie;
Weller, Michael;
Bent, Martin J van den;
Vogelbaum, Michael A;
Chang, Susan M;
Wen, Patrick Y

Publication type:

Article

Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.

Published in:

Neuro-Oncology, 2021, v. 23, n. 8, p. 1252, doi. 10.1093/neuonc/noab082

By:

Lee, Eudocia Q;
Selig, Wendy;
Meehan, Clair;
Bacha, Jeffrey;
Barone, Amy;
Bloomquist, Erik;
Chang, Susan M;
Groot, John F de;
Galanis, Evanthia;
Hassan, Islam;
Kalidas, Chitkala;
Khasraw, Mustafa;
Kvedar, Joseph C;
Lassman, Andrew B;
Puduvalli, Vinay;
Sahebjam, Solmaz;
Schwamm, Lee H;
Tamir, Sharon;
Welch, Mary;
Yung, W K Alfred

Publication type:

Article

A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.

Published in:

Neuro-Oncology, 2021, v. 23, n. 8, p. 1337, doi. 10.1093/neuonc/noab040

By:

Brown, Paul D;
Chung, Caroline;
Liu, Diane D;
McAvoy, Sarah;
Grosshans, David;
Feghali, Karine Al;
Mahajan, Anita;
Li, Jing;
McGovern, Susan L;
McAleer, Mary-Fran;
Ghia, Amol J;
Sulman, Erik P;
Penas-Prado, Marta;
Groot, John F de;
Heimberger, Amy B;
Wang, Jihong;
Armstrong, Terri S;
Gilbert, Mark R;
Guha-Thakurta, Nandita;
Wefel, Jeffrey S

Publication type:

Article

PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O<sup>6</sup>-methylguanine DNA damage in glioblastoma.

Published in:

Neuro-Oncology, 2021, v. 23, n. 6, p. 920, doi. 10.1093/neuonc/noab003

By:

Wu, Shaofang;
Li, Xiaolong;
Gao, Feng;
Groot, John F de;
Koul, Dimpy;
Yung, W K Alfred

Publication type:

Article

Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.

Published in:

Neuro-Oncology, 2021, v. 23, n. 2, p. 284, doi. 10.1093/neuonc/noaa182

By:

Mohan, Radhe;
Liu, Amy Y;
Brown, Paul D;
Mahajan, Anita;
Dinh, Jeffrey;
Chung, Caroline;
McAvoy, Sarah;
McAleer, Mary Frances;
Lin, Steven H;
Li, Jing;
Ghia, Amol J;
Zhu, Cong;
Sulman, Erik P;
Groot, John F de;
Heimberger, Amy B;
McGovern, Susan L;
Grassberger, Clemens;
Shih, Helen;
Ellsworth, Susannah;
Grosshans, David R

Publication type:

Article

Potential neurologic and oncologic implications of the novel coronavirus.

Published in:

Neuro-Oncology, 2020, v. 22, n. 7, p. 1050, doi. 10.1093/neuonc/noaa096

By:

Aaroe, Ashley Elimar;
Majd, Nazanin;
Weathers, Shiao-Pei;
Groot, John Frederick de

Publication type:

Article

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

Published in:

Neuro-Oncology, 2020, v. 22, n. 5, p. 705, doi. 10.1093/neuonc/noz232

By:

Cloughesy, Timothy F;
Brenner, Andrew;
Groot, John F de;
Butowski, Nicholas A;
Zach, Leor;
Campian, Jian L;
Ellingson, Benjamin M;
Freedman, Laurence S;
Cohen, Yael C;
Lowenton-Spier, Noa;
Minei, Tamar Rachmilewitz;
Shmueli, Shifra Fain;
Investigators, GLOBE Study;
Y, Wen Patrick

Publication type:

Article